RiverVest Venture Management’s OnKure Therapeutics OKUR Stock Holding History

RiverVest Venture Management’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$4.31M	Hold	253,422	–	–	63%	1
2024 Q2	$3.83M	Hold	253,422	–	–	56.07%	1
2024 Q1	$4.21M	Hold	253,422	–	–	51.67%	1
2023 Q4	$4.05M	Hold	253,422	–	–	14.95%	3
2023 Q3	$19.3M	Hold	253,422	–	–	47.73%	1
2023 Q2	$16.6M	Buy	253,422 +12,500	+5%	+$1.01M	18.44%	3
2023 Q1	$14.4M	Hold	240,922	–	–	16.67%	3
2022 Q4	$5.61M	Hold	240,922	–	–	6.55%	3
2022 Q3	$8.07M	Hold	240,922	–	–	9.37%	3
2022 Q2	$6.38M	Hold	240,922	–	–	9.38%	3
2022 Q1	$7.08M	Hold	240,922	–	–	7.27%	4
2021 Q4	$20.6M	Hold	240,922	–	–	14.7%	4
2021 Q3	$17.9M	Hold	240,922	–	–	3.01%	3
2021 Q2	$22.5M	Buy	+240,922	New	+$26.9M	4.39%	4

Other funds holding OKUR

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return